Neutrophils in Cancer immunotherapy: friends or foes?

Xueqin Huang,Eugenie Nepovimova,Vojtech Adam,Ladislav Sivak,Zbynek Heger,Marian Valko,Qinghua Wu,Kamil Kuca
DOI: https://doi.org/10.1186/s12943-024-02004-z
IF: 37.3
2024-05-19
Molecular Cancer
Abstract:Neutrophils play a Janus-faced role in the complex landscape of cancer pathogenesis and immunotherapy. As immune defense cells, neutrophils release toxic substances, including reactive oxygen species and matrix metalloproteinase 9, within the tumor microenvironment. They also modulate the expression of tumor necrosis factor-related apoptosis-inducing ligand and Fas ligand, augmenting their capacity to induce tumor cell apoptosis. Their involvement in antitumor immune regulation synergistically activates a network of immune cells, bolstering anticancer effects. Paradoxically, neutrophils can succumb to the influence of tumors, triggering signaling cascades such as JAK/STAT, which deactivate the immune system network, thereby promoting immune evasion by malignant cells. Additionally, neutrophil granular constituents, such as neutrophil elastase and vascular endothelial growth factor, intricately fuel tumor cell proliferation, metastasis, and angiogenesis. Understanding the mechanisms that guide neutrophils to collaborate with other immune cells for comprehensive tumor eradication is crucial to enhancing the efficacy of cancer therapeutics. In this review, we illuminate the underlying mechanisms governing neutrophil-mediated support or inhibition of tumor progression, with a particular focus on elucidating the internal and external factors that influence neutrophil polarization. We provide an overview of recent advances in clinical research regarding the involvement of neutrophils in cancer therapy. Moreover, the future prospects and limitations of neutrophil research are discussed, aiming to provide fresh insights for the development of innovative cancer treatment strategies targeting neutrophils.
oncology,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the dual roles of neutrophils in cancer immunotherapy, that is, they can be both an anti - tumor "friend" and a pro - tumor "enemy". Specifically, the paper aims to reveal how neutrophils interact with other immune cells in the tumor microenvironment and how these interactions affect tumor development and the effectiveness of immunotherapy. In addition, the paper also explores the internal and external factors that affect neutrophil polarization, in order to provide a theoretical basis and new insights for the development of new cancer treatment strategies targeting neutrophils. ### Core issues of the paper: 1. **The dual roles of neutrophils in cancer development**: The paper analyzes in detail the mechanisms by which neutrophils have both anti - tumor and pro - tumor activities in the tumor microenvironment. 2. **The polarization mechanisms of neutrophils**: It explores how different signaling pathways (such as TGF - β and IFN - 1) induce neutrophils to differentiate into different phenotypes (N1 or N2), and the roles of these phenotypes in tumor development. 3. **The potential applications of neutrophils in immunotherapy**: It discusses the role of neutrophils in immunotherapy, including their potential as diagnostic tools and treatment targets. 4. **Opportunities and challenges for future research**: It looks forward to the future directions of neutrophil research and points out the limitations in current research and the problems that need further exploration. Through these discussions, the paper hopes to provide a comprehensive perspective for understanding the complex roles of neutrophils in cancer and provide a scientific basis for the development of new cancer treatment strategies.